These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34086873)

  • 21. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
    Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
    Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
    Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease.
    Wood JH; Guo J; Morrell NW; Li W
    Biochem Soc Trans; 2019 Jun; 47(3):779-791. PubMed ID: 31127068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
    Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
    Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
    David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
    Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale phosphoproteomics reveals activation of the MAPK/GADD45β/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells.
    Al Tarrass M; Belmudes L; Koça D; Azemard V; Liu H; Al Tabosh T; Ciais D; Desroches-Castan A; Battail C; Couté Y; Bouvard C; Bailly S
    Cell Commun Signal; 2024 Mar; 22(1):158. PubMed ID: 38439036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis.
    Somekawa S; Imagawa K; Hayashi H; Sakabe M; Ioka T; Sato GE; Inada K; Iwamoto T; Mori T; Uemura S; Nakagawa O; Saito Y
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12064-9. PubMed ID: 22783020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.
    Castonguay R; Werner ED; Matthews RG; Presman E; Mulivor AW; Solban N; Sako D; Pearsall RS; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2011 Aug; 286(34):30034-46. PubMed ID: 21737454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
    Chomette L; Hupkens E; Romitti M; Dewachter L; Vachiéry JL; Bailly S; Costagliola S; Smits G; Tillet E; Bondue A
    Am J Med Genet A; 2023 Aug; 191(8):2064-2073. PubMed ID: 37249087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
    Tong Z; Guo J; Glen RC; Morrell NW; Li W
    Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection.
    Zhao D; Yang F; Wang Y; Li S; Li Y; Hou F; Yang W; Liu D; Tao Y; Li Q; Wang J; He F; Tang L
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34874921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?
    Upton P; Richards S; Bates A; Niederhoffer KY; Morrell NW; Christian S
    Am J Med Genet A; 2023 Jan; 191(1):228-233. PubMed ID: 36259599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
    Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
    Mitchell D; Pobre EG; Mulivor AW; Grinberg AV; Castonguay R; Monnell TE; Solban N; Ucran JA; Pearsall RS; Underwood KW; Seehra J; Kumar R
    Mol Cancer Ther; 2010 Feb; 9(2):379-88. PubMed ID: 20124460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
    Nikolic I; Yung LM; Yang P; Malhotra R; Paskin-Flerlage SD; Dinter T; Bocobo GA; Tumelty KE; Faugno AJ; Troncone L; McNeil ME; Huang X; Coser KR; Lai CSC; Upton PD; Goumans MJ; Zamanian RT; Elliott CG; Lee A; Zheng W; Berasi SP; Huard C; Morrell NW; Chung RT; Channick RW; Roberts KE; Yu PB
    Am J Respir Crit Care Med; 2019 Apr; 199(7):891-902. PubMed ID: 30312106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.